Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
1.030
+0.119 (13.07%)
At close: Sep 25, 2026, 4:00 PM EDT
1.190
+0.160 (15.53%)
Pre-market: Sep 28, 2026, 9:04 AM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $4.07 million as of September 25, 2026. Its market cap has decreased by -16.99% in one year.
Market Cap
4.07M
Enterprise Value
-1.69M
1-Year Change
-16.99%
Ranking
Category
Stock Price
$1.03
ChartMarket Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $624.51M to $4.07M, a decrease of -99.35%. That is a compound annual growth rate of -66.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 4.07M | 67.68% |
| Dec 31, 2025 | 2.43M | -53.56% |
| Dec 31, 2024 | 5.22M | 43.70% |
| Dec 29, 2023 | 3.64M | -78.64% |
| Dec 30, 2022 | 17.02M | -97.28% |
| Feb 18, 2022 | 624.51M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Dermata Therapeutics | 4.59M |
| GRI Bio | 4.48M |
| Calidi Biotherapeutics | 4.18M |
| 60 Degrees Pharmaceuticals | 4.11M |
| Cadrenal Therapeutics | 4.10M |
| Lakewood-Amedex Biotherapeutics | 3.96M |
| Mustang Bio | 3.94M |
| PMGC Holdings | 3.70M |